We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ANEB

Price
0.94
Stock movement down
-0.04 (-3.60%)
Company name
Anebulo Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
24.50M
Ent value
23.66M
Price/Sales
-
Price/Book
12.90
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-66.02%
3 year return
-49.02%
5 year return
-
10 year return
-
Last updated: 2025-04-09

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ANEB does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book12.90
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count25.93M
EPS (TTM)-0.31
FCF per share (TTM)-0.27

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-8.18M
Net income (TTM)-7.92M
EPS (TTM)-0.31
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.40M
Net receivables0.00
Total current assets1.96M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.47M
Accounts payable252.14K
Short/Current long term debt0.00
Total current liabilities569.23K
Total liabilities569.23K
Shareholder's equity1.90M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-7.05M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-7.05M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-417.21%
Return on Assets-320.98%
Return on Invested Capital-417.21%
Cash Return on Invested Capital-371.52%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.05
Daily high1.13
Daily low0.90
Daily Volume94K
All-time high8.95
1y analyst estimate6.00
Beta-1.01
EPS (TTM)-0.31
Dividend per share-
Ex-div date-
Next earnings date13 May 2025

Downside potential

Loading...
Downside potential data
ANEBS&P500
Current price drop from All-time high-89.44%-10.49%
Highest price drop-89.44%-56.47%
Date of highest drop9 Apr 20259 Mar 2009
Avg drop from high-59.72%-11.07%
Avg time to new high247 days12 days
Max time to new high976 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ANEB (Anebulo Pharmaceuticals Inc) company logo
Marketcap
24.50M
Marketcap category
Small-cap
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.
Employees
2
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...